BLOG / 🇺🇸 United States · · daily

All HHS Contracts — July 07, 2026

All HHS Contracts

By Gunpowder Editorial ·

1 total filings analysed

Executive Summary

The single HHS contract analyzed, a $144.8 million firm-fixed-price award to SAFESOURCE DIRECT LLC, underscores a targeted civilian agency push to onshore critical medical supply chain components, specifically nitrile butadiene rubber (NBR) for gloves. With no defense-related contracts in this period, the digest is purely civilian, carrying an average signal strength of 7.0/10.

The highest-conviction signal is the contract's strong execution, with $118.9 million already outlayed, indicating robust cash flow and performance. A key risk is the contract's expiration in December 2026, creating a re-compete cliff for SAFESOURCE DIRECT LLC.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior All HHS Contracts digest from June 28, 2026.

Investment Signals (1)

  • SAFESOURCE DIRECT LLC Wins $144.8M HHS/ASPR Contract for Domestic NBR Production (HIGH)

    SAFESOURCE DIRECT LLC, a small business, secured a $144.8 million firm-fixed-price contract from HHS/ASPR for industrial base expansion of NBR, a critical material for medical gloves. With $118.9 million already outlayed, the contract signals strong execution and government commitment to domestic supply chain resilience.

Risk Flags (2)

  • Concentration [HIGH RISK]

    SAFESOURCE DIRECT LLC's entire revenue stream is tied to a single $144.8M HHS contract expiring December 2026, creating a re-compete risk. Failure to secure a follow-on award would eliminate nearly all revenue.

  • Competition [MEDIUM RISK]

    The contract was awarded under full and open competition, meaning larger competitors could bid on future NBR production contracts, potentially saturating the market or undercutting SAFESOURCE DIRECT LLC's pricing.

Opportunities (1)

  • HHS/ASPR's investment in domestic NBR production signals sustained budget allocation for pandemic preparedness. SAFESOURCE DIRECT LLC could benefit from follow-on contracts or extensions beyond December 2026, especially if the government expands its industrial base program.

Sector Themes (1)

  • The $144.8M contract to SAFESOURCE DIRECT LLC for NBR production exemplifies HHS/ASPR's strategic push to reduce reliance on foreign medical glove supplies, a theme reinforced by the contract's firm-fixed-price structure and full-and-open competition.

Watch List (2)

  • 👁

    {"entity"=>"SAFESOURCE DIRECT LLC", "reason"=>"Single-contract concentration risk; the company's revenue is entirely dependent on this $144.8M HHS award expiring December 2026.", "trigger"=>"Re-compete announcement or contract extension decision from HHS/ASPR"}

  • 👁

    {"entity"=>"Domestic medical glove supply chain", "reason"=>"HHS/ASPR's industrial base expansion for NBR could lead to additional contracts for other domestic manufacturers of medical gloves or related PPE.", "trigger"=>"New HHS/ASPR solicitations for NBR production or medical glove manufacturing"}

Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: All HHS Contracts

🇺🇸 More from United States

View all →